Clinical Data Highlight PlaCCine's Six-Month Durability, Temperature Stability, and Manufacturing Advantages Over mRNA Vaccines IMUNON Seeks Strategic Partner for PlaCCine® to Advance Novel Technology ...

Scientists have designed a DNA scaffold that carries HIV vaccine proteins into the body and sharpens the immune response against the virus. One of the biggest hurdles in developing an HIV vaccine is ...

In a paper published in the Journal of Clinical Investigation, a research team at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health reports developing a therapeutic ...

The immunogenic protein associated with a recombinant DNA vaccine is made in the laboratory and injected into the vaccine recipient, while the immunogenic protein associated with a DNA vaccine is ...

A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can hide from antibiotics. In animal studies, it helped clear infections faster, ...

An adjuvant personalized DNA vaccine was safe and demonstrated promising efficacy among patients with MGMT-unmethylated glioblastoma in a phase I trial. The vaccine caused no serious adverse events ...

The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...

Therapeutic cancer vaccines are having a moment. A comprehensive review published in Clinical Cancer Bulletin by Chiyuan Wang ...